- Home
- ERAS vs NAT Comparison
ERAS vs NAT Comparison
Compare ERAS & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERAS | NAT |
|---|---|---|
| Founded | 2018 | 1995 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 902.1M |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ERAS | NAT |
|---|---|---|
| Price | $12.18 | $4.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $5.78 | $3.25 |
| AVG Volume (30 Days) | ★ 7.1M | 2.8M |
| Earning Date | 03-19-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 7.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $294,820,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.97 |
| P/E Ratio | ★ N/A | $479.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.01 | $2.13 |
| 52 Week High | $12.48 | $4.38 |
Technical Indicators
Market Signals| Indicator | ERAS | NAT |
|---|---|---|
| Relative Strength Index (RSI) | 81.12 | 71.71 |
| Support Level | $9.05 | $4.01 |
| Resistance Level | $12.48 | $4.25 |
| Average True Range (ATR) | 0.71 | 0.12 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 87.76 | 88.71 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.